Thiethylperazine
From Wikipedia, the free encyclopedia
 |
|
|
Thiethylperazine
|
|
| Systematic (IUPAC) name | |
| 2-ethylsulfanyl-10-[3- (4-methylpiperazin-1-yl)propyl]- 10H-phenothiazine | |
| Identifiers | |
| CAS number | |
| ATC code | R06 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C22H29N3S2 |
| Mol. mass | 399.618 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 60% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Thiethylperazine is a piperazine phenothiazine. It is approved for treating of nausea and vomiting.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
